Kastritis, Efstathios Roussou, Maria Gavriatopoulou, Maria Migkou, Magdalini Kalapanida, Despina Pamboucas, Constantinos Kaldara, Elisavet Ntalianis, Argyrios Psimenou, Erasmia Toumanidis, Savvas T others, Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies, American Journal of Hematology, (90), E60--E65, 2015, 0361-8609, 1096-8652